The company is a picture of financial stability.

The rising popularity of GLP-1 drugs is a big reason why investors are bullish on the anti-obesity market. GLP-1 drugs, however, need to be taken on an ongoing basis and come with risks.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Sovran Advisors LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 96.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,921 shares of the medical equipment provider's stock after purchasing an additional 1,433 shares during

Stratos Wealth Partners LTD. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 12.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,453 shares of the medical equipment provider's stock after acquiring an additional 2,123 shares during the period.

GraniteShares Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 80.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 566 shares of the medical equipment provider's stock after selling 2,351 shares during the quarter. GraniteShares Advisors LLC's holdings

Holiday shoppers look for “For Sale” signs, while those shopping during Thanksgiving seek out bargains. In retail, a reduction in price is an invitation to act.

ISRG faces rising pricing pressure in China as local rivals gain ground, but its ecosystem, local manufacturing and disciplined pricing aim to defend its position.

American Express leads featured reports as spending growth and digital investments drive gains, while Intuitive Surgical and Shopify show mixed momentum.

Compagnie Lombard Odier SCmA boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 27.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 48,035 shares of the medical equipment provider's stock after acquiring an additional 10,314 shares